查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957754

2026年全球核糖核酸（RNA）编辑市场报告

Ribonucleic Acid (RNA) Editing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，核糖核酸（RNA）编辑市场发展迅速。预计该市场规模将从2025年的175.5亿美元成长到2026年的190.9亿美元，复合年增长率（CAGR）为8.8%。过去几年推动这一增长的成长要素包括RNA编辑技术的局限性、遗传疾病发病率的上升趋势、癌症靶向RNA疗法的早期研究、缺乏标准化的编辑通讯协定以及分子生物学领域学术研究的增加。

预计未来几年核糖核酸（RNA）编辑市场将维持强劲成长，到2030年市场规模将达到264.8亿美元，复合年增长率（CAGR）为8.5%。预测期内的成长要素包括RNA介导的Adenosine deaminase（ADAR）编辑技术的开发、精准医疗投资的增加、RNA编辑与基因治疗的融合、RNA疗法临床试验的扩展以及生物技术公司与製药公司之间合作的加强。预测期内的关键趋势包括传讯RNA（mRNA）编辑技术的进步、转移RNA（tRNA）治疗应用的发展、核醣体RNA（rRNA）调控研究的拓展、对癌症和遗传疾病治疗日益增长的关注，以及特异性编辑和碱基编辑技术的应用。

遗传疾病的日益增多预计将推动核糖核酸（RNA）编辑市场的成长。遗传疾病是由DNA突变或缺失引起的，这些突变或缺失可能是遗传自父母，也可能是后天发生的。遗传疾病的增加与高龄生产有关，因为高龄产妇会增加染色体异常的机率。 RNA编辑透过在不改变DNA的情况下纠正RNA缺陷来解决遗传疾病，从而确保蛋白质的正常合成。例如，美国疾病管制与预防中心（CDC）在2024年5月估计，镰状细胞疾病（SCD）影响10万美国人。因此，遗传疾病盛行率的上升正在推动RNA编辑市场的发展。

RNA编辑市场的主要企业正透过体内基因编辑等开创性方法，在活体受试者中实现精准有效的突变矫正。体内基因编辑直接修改活体组织中的基因，以修復缺陷或调节基因表达，以达到治疗目的。例如，2024年4月，美国非营利组织雷特症候群研究信託基金成立了MECP2编辑联盟，汇集了六家顶尖实验室。该联盟旨在开发针对雷特氏症根本病因的DNA和RNA编辑技术，并迅速推进临床试验。这项合作研究汇集了各机构的专业知识，旨在为严重的脑部疾病创造精准且具有潜在治疗价值的方案。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球核糖核酸（RNA）编辑市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 传讯RNA（mRNA）编辑技术的进展
    • 转移RNA（tRNA）治疗应用技术的发展
    • 拓展对核醣体RNA（rRNA）调控的研究
    • 人们越来越关注癌症和遗传疾病的治疗
    • 采用网站特异性编辑和基础编辑技术

第五章 终端用户产业市场分析

  • 生技公司
  • 製药公司
  • 研究机构
  • 学术研究机构
  • 受託研究机构（CRO）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球核糖核酸（RNA）编辑市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球核糖核酸（RNA）编辑市场规模、比较及成长率分析
  • 全球核糖核酸（RNA）编辑市场表现：规模与成长，2020-2025年
  • 全球核糖核酸（RNA）编辑市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 信使核糖核酸（mRNA）修饰、转移核糖核酸（tRNA）修饰、核醣体核糖核酸（rRNA）修饰
  • 透过技术
  • 插入或删除，脱氨基作用
  • 透过使用
  • 癌症、遗传性疾病、暂时性疾病
  • 依类型细分：信使核糖核酸 (mRNA) 修饰
  • 碱基编辑，Adenosine deaminase对核糖核酸（RNA）的编辑，位点特异性核糖核酸（RNA）编辑
  • 依类型细分：转移核糖核酸（RNA）（tRNA）修饰
  • 转座核糖核酸剪接，肌苷修饰
  • 依类型细分：核醣体核糖核酸 (RNA) (rRNA) 修饰
  • 假尿苷化、核醣体RNA成熟途径的调控、位点特异性核醣体RNA编辑

第十章 区域与国别分析

  • 全球核糖核酸（RNA）编辑市场：依地区划分，历史资料及预测，2020-2025年、2025-2030年、2035年
  • 全球核糖核酸（RNA）编辑市场：依国家划分，实际值和预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 核糖核酸（RNA）编辑市场：竞争格局与市场份额，2024年
  • 核糖核酸（RNA）编辑市场：公司估值矩阵
  • 核糖核酸（RNA）编辑市场：公司概况
    • Beam Therapeutics Inc.
    • EdiGene Inc.
    • Deep Genomics Incorporated
    • ADARx Pharmaceuticals Inc.
    • Storm Therapeutics Limited

第37章 其他大型企业和创新企业

  • Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家、细分市场与策略

  • 2030年核糖核酸（RNA）编辑市场：提供新机会的国家
  • 2030年核糖核酸（RNA）编辑市场：充满新机会的细分领域
  • 2030年核糖核酸（RNA）编辑市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH4MRARE01_G26Q1

Ribonucleic acid (RNA) editing is a post-transcriptional process that modifies the nucleotide sequence of RNA molecules after they are transcribed from deoxyribonucleic acid (DNA). These changes can alter the structure or function of the resulting proteins, impacting gene expression and offering potential therapeutic applications.

The main types of RNA editing include messenger RNA (mRNA) modification, transfer RNA (tRNA) modification, and ribosomal RNA (rRNA) modification. Messenger RNA modification involves chemical alterations to mRNA molecules after transcription, such as methylation or nucleotide sequence editing. Common techniques include insertion, deletion, and deamination. These modifications are applied in areas such as cancer, genetic disorders, and temporary medical conditions.

Tariffs have impacted the RNA editing market by increasing costs of imported gene-editing enzymes, reagents, and laboratory instruments used for mRNA, tRNA, and rRNA modifications. Segments like site-directed RNA editing and base editing technologies are most affected, particularly in regions such as North America and Europe, which rely on imported reagents and specialized equipment. While tariffs have increased operational costs and slowed research supply chains, they have also encouraged local production of reagents, innovation in RNA editing platforms, and investment in domestic biotech capabilities.

The ribonucleic acid (rna) editing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) editing market statistics, including ribonucleic acid (rna) editing industry global market size, regional shares, competitors with a ribonucleic acid (rna) editing market share, detailed ribonucleic acid (rna) editing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) editing industry. This ribonucleic acid (rna) editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (rna) editing market size has grown strongly in recent years. It will grow from $17.55 billion in 2025 to $19.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited rna editing technologies, growing prevalence of genetic disorders, early research on cancer-targeted rna therapies, lack of standardized editing protocols, increasing academic research in molecular biology.

The ribonucleic acid (rna) editing market size is expected to see strong growth in the next few years. It will grow to $26.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to development of adenosine deaminase acting on rna (adar)-mediated editing, rising investment in precision medicine, integration of rna editing with gene therapy, expansion of clinical trials for rna therapeutics, increasing collaborations between biotech and pharmaceutical companies. Major trends in the forecast period include advancements in messenger rna (mrna) editing technologies, development of transfer rna (trna) therapeutic applications, expansion of ribosomal rna (rrna) modulation research, increasing focus on cancer and genetic disorder treatments, adoption of site-directed and base editing techniques.

The uptick in genetic disorders is anticipated to fuel the ribonucleic acid (RNA) editing market ahead. Genetic disorders arise from DNA alterations or mutations, passed from parents or emerging anew. Their increase ties to older parenthood, elevating odds of chromosomal glitches. Ribonucleic acid (RNA) editing counters genetic disorders by fixing RNA flaws, enabling proper protein output sans DNA changes. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US public health body, estimated sickle cell disease (SCD) impacts 100,000 Americans. Thus, the rising genetic disorders are boosting the ribonucleic acid (RNA) editing market.

Prominent companies in the ribonucleic acid (RNA) editing market are pioneering methods like in vivo gene editing for pinpoint, effective mutation fixes in live subjects. In vivo gene editing directly tweaks genes in living tissues to mend flaws or adjust expression for healing. For instance, in April 2024, the Rett Syndrome Research Trust, a US non-profit, formed the MECP2 Editing Consortium uniting six top labs to craft DNA and RNA edits targeting Rett syndrome's root cause, fast-tracking to trials. This teamwork harnesses collective skills for accurate, possibly healing options against the grave brain disorder.

In May 2025, Rznomics Inc., a South Korea biopharma, allied with Eli Lilly and Company to craft and market RNA-editing therapies for sensorineural hearing loss via Rznomics' trans-splicing ribozyme tech-Rznomics leads early research, Lilly late-stage and worldwide launch. Eli Lilly and Company is a US pharma powerhouse backing RNA editing for targeted genetic and rare disease fixes.

Major companies operating in the ribonucleic acid (rna) editing market are Beam Therapeutics Inc., EdiGene Inc., Deep Genomics Incorporated, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX.

North America was the largest region in the ribonucleic acid (RNA) editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna) editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (rna) editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Editing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ribonucleic acid (rna) editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Messenger Ribonucleic Acid (RNA) Modification; Transfer Ribonucleic Acid (RNA) Modification; Ribosomal Ribonucleic Acid (RNA) Modification
  • 2) By Technique: Insertion Or Deletion; Deamination
  • 3) By Application: Cancer; Genetic Disorders; Temporary Maladies
  • Subsegments:
  • 1) By Messenger Ribonucleic Acid(RNA) (Mrna) Modification: Base Editing; Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing; Site-Directed Ribonucleic Acid (RNA) Editing
  • 2) By Transfer Ribonucleic Acid (RNA) (Trna) Modification: Pseudouridylation; Transfer Ribonucleic Acid Splicing; Inosine Modification
  • 3) By Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification: Pseudouridylation; Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation; Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
  • Companies Mentioned: Beam Therapeutics Inc.; EdiGene Inc.; Deep Genomics Incorporated; ADARx Pharmaceuticals Inc.; Storm Therapeutics Limited; Ascidian Therapeutics Inc.; Korro Bio Inc.; Shape TX.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ribonucleic Acid (RNA) Editing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ribonucleic Acid (RNA) Editing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ribonucleic Acid (RNA) Editing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ribonucleic Acid (RNA) Editing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advancements In Messenger RNA (mRNA) Editing Technologies
    • 4.2.2 Development Of Transfer RNA (tRNA) Therapeutic Applications
    • 4.2.3 Expansion Of Ribosomal RNA (rRNA) Modulation Research
    • 4.2.4 Increasing Focus On Cancer And Genetic Disorder Treatments
    • 4.2.5 Adoption Of Site-Directed And Base Editing Techniques

5. Ribonucleic Acid (RNA) Editing Market Analysis Of End Use Industries

  • 5.1 Biotechnology Companies
  • 5.2 Pharmaceutical Companies
  • 5.3 Research Institutes
  • 5.4 Academic Laboratories
  • 5.5 Contract Research Organizations (CROs)

6. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ribonucleic Acid (RNA) Editing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ribonucleic Acid (RNA) Editing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ribonucleic Acid (RNA) Editing Market Segmentation

  • 9.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification
  • 9.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insertion Or Deletion, Deamination
  • 9.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer, Genetic Disorders, Temporary Maladies
  • 9.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid (RNA) Editing
  • 9.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid (RNA) (Trna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification
  • 9.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

10. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

  • 10.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

  • 11.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ribonucleic Acid (RNA) Editing Market

  • 12.1. China Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ribonucleic Acid (RNA) Editing Market

  • 13.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ribonucleic Acid (RNA) Editing Market

  • 14.1. Japan Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ribonucleic Acid (RNA) Editing Market

  • 15.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ribonucleic Acid (RNA) Editing Market

  • 16.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ribonucleic Acid (RNA) Editing Market

  • 17.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ribonucleic Acid (RNA) Editing Market

  • 18.1. Taiwan Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ribonucleic Acid (RNA) Editing Market

  • 19.1. South East Asia Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ribonucleic Acid (RNA) Editing Market

  • 20.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ribonucleic Acid (RNA) Editing Market

  • 21.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ribonucleic Acid (RNA) Editing Market

  • 22.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ribonucleic Acid (RNA) Editing Market

  • 23.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ribonucleic Acid (RNA) Editing Market

  • 24.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ribonucleic Acid (RNA) Editing Market

  • 25.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ribonucleic Acid (RNA) Editing Market

  • 26.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ribonucleic Acid (RNA) Editing Market

  • 27.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ribonucleic Acid (RNA) Editing Market

  • 28.1. North America Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ribonucleic Acid (RNA) Editing Market

  • 29.1. USA Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ribonucleic Acid (RNA) Editing Market

  • 30.1. Canada Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ribonucleic Acid (RNA) Editing Market

  • 31.1. South America Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ribonucleic Acid (RNA) Editing Market

  • 32.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ribonucleic Acid (RNA) Editing Market

  • 33.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ribonucleic Acid (RNA) Editing Market

  • 34.1. Africa Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ribonucleic Acid (RNA) Editing Market Regulatory and Investment Landscape

36. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

  • 36.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ribonucleic Acid (RNA) Editing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ribonucleic Acid (RNA) Editing Market Company Profiles
    • 36.3.1. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Deep Genomics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. ADARx Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Storm Therapeutics Limited Overview, Products and Services, Strategy and Financial Analysis

37. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

  • Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX

38. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

40. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

  • 40.1 Ribonucleic Acid (RNA) Editing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Ribonucleic Acid (RNA) Editing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Ribonucleic Acid (RNA) Editing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer